Ashley Cordova, Chief Executive Officer at NovoCure Ltd (NVCR), bought 81,550 shares at $12.22 ($997K) on 2025-09-05, disclosed to the SEC on 2025-09-08.
Seasonal purchase ($997k) by Chief Executive Officer — this insider has traded NVCR in September in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| NVCR | SELL | 2024-08-05 | $14K | — | Filing → |
| NVCR | SELL | 2023-09-05 | $19K | — | Filing → |
| NVCR | SELL | 2023-08-04 | $35K | — | Filing → |